Stocks · Financials · Blank Checks

Drugs Made In America Acquisition II Corp.

DMII Clue Score59

United States Fiscal year ends December CIK 0002040475

$10.19 +0.00% Close, 9 Oct 2026

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

10.19 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$4.19M

Free cash flow

$1.02M

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
26 Sep 2025	Stockwell Lynn CEO and Exe. Chair of Board	Bought	n/a	4.9%
26 Sep 2025	Drugs Made In America Acquisition II LLC 10% owner	Bought	n/a	4.9%
26 Sep 2025	Stockwell Lynn CEO and Exe. Chair of Board	Sold at will	n/a	54.3%
26 Sep 2025	Drugs Made In America Acquisition II LLC 10% owner	Sold at will	n/a	54.3%

59out of 100

Profitability 100

Financial strength 17

Growth n/a

Insiders 50

Strongest on profitability (100), weakest on financial strength (17). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan